FDA Clearance Tracker · P000040-S015
GENESYS HTA SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 16, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Jul 16, 2010
Approved
Time to decision
53 days
Received May 24, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P000040-S015
- Device name
- GENESYS HTA SYSTEM
- Applicant
- Axora Medical, Inc.
- Applicant location
- Jacksonville, FL
- Received
- May 24, 2010
- Decided
- Jul 16, 2010
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P000040
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Axora Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260984 · Decided Aug 18, 2026 · 146 days after receipt
Device type: Hysteroscope (And Accessories) (HIH) · Obstetrics & Gynecology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.